tiprankstipranks
KH Neochem Co.,Ltd. (JP:4189)
:4189
Japanese Market
Want to see JP:4189 full AI Analyst Report?

KH Neochem Co.,Ltd. (4189) AI Stock Analysis

2 Followers

Top Page

JP:4189

KH Neochem Co.,Ltd.

(4189)

Select Model
Select Model
Select Model
Neutral 67 (OpenAI - 5.2)
Rating:67Neutral
Price Target:
¥2,881.00
▲(16.31% Upside)
Action:Reiterated
Date:02/11/26
The score is driven primarily by solid underlying financial stability (notably conservative leverage) but tempered by mixed operating performance and historically uneven free cash flow. Technicals are supportive of an uptrend but look overextended, while valuation is a meaningful positive with a moderate P/E and strong dividend yield.
Positive Factors
Conservative balance sheet
Sustained low leverage gives the company durable financial flexibility in the cyclical chemicals industry. Lower debt reduces refinancing and liquidity risk, supports capital spending or dividends through cycles, and enables tactical investments or M&A without stressing the balance sheet.
Negative Factors
Top-line volatility
Choppy revenue and recent declines signal cyclicality and weaker pricing/demand in end markets. Persistent top-line variability undermines predictable capacity utilization and investment planning, making it harder to sustain margin improvements or consistent free-cash-flow generation over time.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
Sustained low leverage gives the company durable financial flexibility in the cyclical chemicals industry. Lower debt reduces refinancing and liquidity risk, supports capital spending or dividends through cycles, and enables tactical investments or M&A without stressing the balance sheet.
Read all positive factors

KH Neochem Co.,Ltd. (4189) vs. iShares MSCI Japan ETF (EWJ)

KH Neochem Co.,Ltd. Business Overview & Revenue Model

Company Description
KH Neochem Co., Ltd. researches, manufactures, and sells petrochemical products in Japan and internationally. It offers a range of chemical products, such as alcohols, esters, ketones, glycol ethers, synthetic fatty acids, aldehydes, diols, hydroc...
How the Company Makes Money
KH Neochem primarily makes money by manufacturing and selling chemical products (chemical intermediates) to business customers. Its revenue model is based on: (1) Product sales of oxo alcohols, carboxylic acids, and ester-related products—sold as ...

KH Neochem Co.,Ltd. Financial Statement Overview

Summary
Balance sheet strength is the key positive (conservative and improving leverage; steady low-teens ROE). Offsetting this, income statement trends are mixed with a ~6% revenue decline in 2025 and margins well below the 2021 peak, while cash flow has been volatile despite a strong 2025 rebound and improved conversion.
Income Statement
62
Positive
Balance Sheet
74
Positive
Cash Flow
58
Neutral
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue122.59B115.10B119.76B115.22B114.88B117.11B
Gross Profit26.90B24.87B25.25B21.94B24.45B32.23B
EBITDA19.04B17.58B17.17B14.60B16.75B24.19B
Net Income8.99B7.80B8.36B6.83B8.07B13.69B
Balance Sheet
Total Assets125.88B130.10B131.46B124.50B131.25B122.07B
Cash, Cash Equivalents and Short-Term Investments5.40B6.72B7.16B9.68B10.93B16.93B
Total Debt20.47B18.29B19.20B16.39B22.52B20.16B
Total Liabilities55.23B57.47B59.54B58.00B69.18B64.56B
Stockholders Equity67.80B69.68B69.09B63.74B59.35B54.92B
Cash Flow
Free Cash Flow0.009.13B-1.45B8.11B-5.27B13.36B
Operating Cash Flow0.0013.78B6.98B13.20B5.13B17.40B
Investing Cash Flow0.00-4.63B-8.90B-4.94B-10.08B-4.39B
Financing Cash Flow0.00-9.57B-645.00M-9.50B-1.08B-5.17B

KH Neochem Co.,Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price2477.00
Price Trends
50DMA
2759.00
Positive
100DMA
2748.80
Positive
200DMA
2674.85
Positive
Market Momentum
MACD
-2.42
Negative
RSI
55.62
Neutral
STOCH
80.08
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4189, the sentiment is Positive. The current price of 2477 is below the 20-day moving average (MA) of 2714.35, below the 50-day MA of 2759.00, and below the 200-day MA of 2674.85, indicating a bullish trend. The MACD of -2.42 indicates Negative momentum. The RSI at 55.62 is Neutral, neither overbought nor oversold. The STOCH value of 80.08 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4189.

KH Neochem Co.,Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
¥45.18B8.513.53%-7.83%13.79%
74
Outperform
¥132.47B49.210.67%8.51%-17.90%
73
Outperform
¥187.27B13.864.41%3.80%-4.32%27.07%
67
Neutral
¥103.06B13.183.88%-8.00%-7.64%
64
Neutral
¥875.08B20.614.79%4.21%-4.09%-27.31%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
60
Neutral
¥494.02B153.051.02%3.37%-1.80%-85.21%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4189
KH Neochem Co.,Ltd.
2,778.00
387.06
16.19%
JP:3405
Kuraray Co
1,640.50
-122.65
-6.96%
JP:4045
Toagosei Co
1,759.00
417.45
31.12%
JP:4042
Tosoh
2,750.00
730.41
36.17%
JP:4970
Toyo Gosei Co., Ltd.
16,690.00
12,177.99
269.90%
JP:5013
Yushiro Chemical Industry Co., Ltd.
3,320.00
1,393.57
72.34%

KH Neochem Co.,Ltd. Corporate Events

KH Neochem to Boost Board Benefit Trust with ¥55 Million Share Purchase
May 11, 2026
KH Neochem Co., Ltd. has approved an additional funding contribution to its Board Benefit Trust, a performance-linked share-based remuneration scheme for directors and corporate officers. The trust, established with Mizuho Trust Banking and using...
KH Neochem First-Quarter Profit Falls but Keeps 2026 Outlook and Higher Dividend Plan
May 11, 2026
KH Neochem reported a decline in first-quarter 2026 results, with net sales falling 11.2% year on year to ¥25.58 billion and operating income dropping 22.6% to ¥2.09 billion, while net income attributable to owners of the parent decrease...
KH Neochem Sees Strategic Capital Emerge as Largest Shareholder
Mar 18, 2026
KH Neochem has announced a shift in its major shareholder structure after Strategic Capital, Inc. increased its stake to become the largest shareholder by voting rights. Strategic Capital, an investment management firm led by President and CEO Tsu...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 11, 2026